Cover Image
Market Research Report

Global Musculoskeletal Drugs Market 2011-2015

Published by TechNavio (Infiniti Research Ltd.) Product code 242745
Published Content info 37 Pages
Immediate Delivery Available
Not Available
Back to Top
Global Musculoskeletal Drugs Market 2011-2015
Published: May 21, 2012 Content info: 37 Pages

This publication has been discontinued on November 12, 2015.


TechNavio's analysts forecast the Global Musculoskeletal Drugs market to grow at a CAGR of 14.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of musculoskeletal diseases. The Global Musculoskeletal Drugs market has also been witnessing the increasing use of drugs for treatment of multiple diseases. However, the upcoming patent expiries of top-selling drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Musculoskeletal Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Musculoskeletal Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Abbott Laboratories Inc., Eli Lilly and Co., Johnson and Johnson Services Inc., and Pfizer Inc.

Key questions answered in this report:

  • What will the market size be in 2015 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?
Table of Contents
Product Code: IRTNTR1194

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Geographical Segmentation

06. Key Leading Countries

07. Rate of Incidence and Prevalence

08. Vendor Landscape

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

  • 15.1. Pfizer Inc.
  • 15.2. Abbott Laboratories Inc.
  • 15.3. Eli Lilly and Co.
  • 15.4. Johnson & Johnson Services Inc.

16. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Global Musculoskeletal Drugs Market 2011-2015 (US$ billion)
  • Exhibit 2: Global Musculoskeletal Drugs Market Segmentation by Drug Use 2011
  • Exhibit 3: Global Musculoskeletal Drugs market by Geographical Segmentation 2011
  • Exhibit 4: Global Musculoskeletal Drugs market by Vendor Segmentation 2011
Back to Top